FDA Recall Terminated

Randox Mg R1 - Product Usage: For the quantitative in vitro determination of Magnesium in serum, plasma and urine Catalogue Number: MG3880

Recall: Z-0546-2021 · Initiated November 13, 2020

Recall

Recall Number
Z-0546-2021
Event Number
86827
Firm
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
FEI Number
1000361607
Product Code
JGJ
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
November 13, 2020
Terminated
April 1, 2021

Description

Randox Mg R1 - Product Usage: For the quantitative in vitro determination of Magnesium in serum, plasma and urine Catalogue Number: MG3880

Reason

Failing to meet the linearity performance claims quoted on the kit inserts-The linearity is reduced by approximately -30% for Serum/ Plasma and -50% for Urine

Action

Randox issued Urgent Medical Device Correction letter via e-mail to US Customers on 13 November 2020 stating reason for recall, health risk and action to take: Discontinue use of and discard any of the above immediately. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to technical. [email protected] within five working days. Questions or concerns, please contact Randox Technical Services.

Distribution

US Nationwide distribution in the states of GA, NJ.

Quantity

1 kit